Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Pharmobedient is a specialized Contract Research Organization (CRO) headquartered in Beijing, China, that focuses on regulatory affairs and clinical trial services. Established in 2003, the company provides a comprehensive suite of services including drug and medical device registration, clinical trial design, monitoring, and pharmacovigilance. They are particularly known for their expertise in navigating the complex regulatory landscape of the National Medical Products Administration (NMPA). Pharmobedient supports both domestic Chinese pharmaceutical companies and international biotechs in achieving market authorization and maintaining compliance. Their team consists of experienced regulatory professionals and clinical researchers dedicated to accelerating the drug development process in the Chinese market. The company acts as a bridge for global firms looking to enter the rapidly growing Chinese healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Pharmobedient.